EUVIMED · CrossrefZeitschrift
Hepatology
ISSN 0270-9139 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Digital pathology in hepatocellular carcinoma: From prognostic prediction to biological understanding and precision medicine
Remote patient management reduces liver-related hospitalizations in patients with acutely decompensated cirrhosis
AASLD EXPO: Diagnosis and management of hepatitis delta virus (HDV) infection
Introducing Michael Ronan Lucey, MD, the 78th President of AASLD
2026 Late Breaking Abstracts
Elafibranor for primary biliary cholangitis at ALP below 1.67 × ULN: Progress toward a goal, no evidence yet of arrival
Treatment with elafibranor to normalize alkaline phosphatase in patients with primary biliary cholangitis and incomplete response to ursodeoxycholic acid: Results from the phase III randomized controlled ELSPIRE trial
ATTEST 2027: A Framework for AI Transparency Tiered by Evidentiary Stakes
MRI-based biomarkers for risk stratification and assessment of treatment response in Metabolic dysfunction-associated Steatotic liver disease
Cell therapies and liver organogenesis technologies: Promising strategies for end-stage liver disease
Hepatectomy alters adjuvant anti–PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy
Glutamine synthetase loss in β-catenin–mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogramming
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)
Myeloid CD36 deficiency alleviates hepatic fibrosis by promoting adaptive immunity of macrophages
Acute-on-chronic liver failure: A global multisociety consensus on definitions
Phase 1b study of miricorilant in patients with presumed metabolic dysfunction–associated steatohepatitis (MASH)
Baveno VI criteria validation and development of a new non-invasive strategy for varices rule-out in patients with HCC (SAPHE-R: Stiffness, ALBI, Platelets, HEpatocellular carcinoma Rule)
Apolipoproteins in HBV infection: ApoC1 links HBV entry, morphogenesis, and cholesterol homeostasis
Upholding telomeres prevents hepatic stellate cell transdifferentiation and liver fibrogenesis
Pioneering precision: The evolution of immunotherapy for hepatocellular carcinoma
Response evaluation to systemic therapy in HCC: Current challenges and future perspectives
Anatomic subsets of cholangiocarcinoma: More different than alike
Hepatitis B virus proteome analysis identifies apolipoprotein C1 facilitating particle production and virus entry
Telehealth versus in-person early palliative care for patients with cirrhosis: An ancillary study from the multi-center PAL-LIVER trial
Portal sinusoidal vascular diseases: Assessment and therapy
Hepatic stellate cell heterogeneity: Functional aspects and therapeutic implications
GPC3-based circular RNA vaccine suppresses hepatocellular carcinoma progression by activating adaptive immune responses
Biology-driven stratification of advanced biliary tract cancer treated with nab-paclitaxel plus gemcitabine–cisplatin: A prospective observational cohort study
Hepatic STEAP4 promotes liver regeneration by regulating lysosomal iron homeostasis and membrane integrity in acetaminophen-induced liver injury
Safety and efficacy of zetomipzomib in relapsed or insufficiently responding autoimmune hepatitis: Results from the randomized, double-blind, placebo-controlled, phase 2a PORTOLA study and open-label extension
Jahrgänge
2026 · 3942025 · 5292024 · 3972023 · 4972022 · 5432021 · 7022020 · 5322019 · 6122018 · 6362017 · 6102016 · 7232015 · 6792014 · 7142013 · 7322012 · 5882011 · 6242010 · 7452009 · 6682008 · 6322007 · 5382006 · 4732005 · 4652004 · 5432003 · 1.9122002 · 5932001 · 4552000 · 4511999 · 5191998 · 5111997 · 9121996 · 1.1101995 · 2.9271994 · 1.3771993 · 2.1111992 · 5191991 · 9131990 · 4481989 · 3941988 · 3241987 · 304
EUVIMED